Measuring Growth and Evaluating Pubertal Development in Pediatric Clinical Trials; Draft Guidance for Industry; Availability
Docket Number: FDA-2022-D-0760 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of New Drugs This guidance is intended to assist sponsors in monitoring growth and, when appropriate, pubertal development in clinical trials …